Plasma Exchange in Neuroimmunological Disorders
Author(s) -
Helmar C. Lehmann,
Hans-Peter Hartung,
Gerd R. Hetzel,
Olaf Stüve,
Bernd C. Kieseier
Publication year - 2006
Publication title -
archives of neurology
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1538-3687
pISSN - 0003-9942
DOI - 10.1001/archneur.63.7.930
Subject(s) - therapeutic plasma exchange , myasthenia gravis , pathognomonic , medicine , multiple sclerosis , etiology , guillain barre syndrome , immunology , autoantibody , neuroimmunology , immune system , disease , antibody
Plasma exchange is a well-established therapeutic procedure commonly used in many neurological disorders of autoimmune etiology. It is thought that the beneficial effects of plasma exchange occur through the elimination of pathognomonic inflammatory mediators, including autoantibodies, complement components, and cytokines. In various neurological disorders, randomized controlled studies have demonstrated the efficacy of plasma exchange (eg, in Guillain-Barré syndrome and other forms of immune neuropathies). Although widely used, the potential benefit of plasma exchange in the treatment of multiple sclerosis, myasthenia gravis, and Lambert-Eaton syndrome is less clear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom